Texas Oncology Ventures | Activity | F4
Texas Oncology Ventures Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
3 essays · JUN 2026 – AUG 2026 Show all Essay
Essay analyzing the WHO's 2026 report on global cancer trends. World Health Organization's 2026 Report on Cancer
oncologyventures.substack.com
AUG 12, 2026
Essay
Essay laying out a playbook for funding cancer care innovation. A Working Playbook for Funding Cancer Innovation
Essay
Essay on the current state of early cancer detection technology. State of Early Detection in Cancer
New Fund
Closed oversubscribed $32M Fund I, surpassing its $30M target, anchored by City of Hope, Moffitt Cancer Center, Cardinal Health, and Atlantic Health. Fund I — $32M oversubscribed
Added recently
News
Announced a strategic collaboration with Texas Oncology, the largest physician-led oncology network in America, embedding portfolio companies within community oncology delivery systems. Strategic Collaboration with Texas Oncology
Added recently
Investment
Invested in Colla Health, an EHR-integrated behavioral health and measurement-based care platform for oncology practices. Colla Health
Investment
Participated in Modicus Prime's $8M total funding round for AI compliance infrastructure in pharma, led by Frist Cressey Ventures. Modicus Prime
New Fund
Closed an oversubscribed $62M Fund II, anchored by Texas Oncology and other leading cancer care institutions. Fund II
Investment
Backed Health Universe's $6M seed round (2026), led by Kleiner Perkins, for its enterprise AI agent platform automating healthcare workflows. Health Universe
New Fund
Closed oversubscribed $62M Fund II, nearly double the $32M Fund I, anchored by Texas Oncology alongside Moffitt, City of Hope, Cardinal Health, Atlantic Health, and Fred Hutch. Fund II — $62M oversubscribed
Investment
Invested in Kadance, a genomics-based precision health management program integrating hereditary cancer risk testing into insurance products. Kadance
Investment
Participated in NexCure's $19M Series A to enable outpatient CAR-T and advanced therapy delivery infrastructure. NexCure
News
Announced a strategic collaboration with Texas Oncology, the largest physician-led oncology network in America, to give portfolio companies real-world clinical validation. Strategic collaboration with Texas Oncology
Essay
Essay arguing for hospitality-grade service design in cancer care delivery. What if Cancer Care Operated Like The Ritz-Carlton